i think the stock price will take care of itself. >> reporter: the healthcare insurance reform legislation may be settled law but another supreme court case this spring could have a big impact on the generic drug business. come april, the supreme court will hear arguments over whether so-called pay for delay arrangements are legal. in their simplest form, large drug companies pay generic makers to delay producing generic versions of drugs. >> are you preparing for either a win or a loss? it's hard for me to foresee an outright ban of settlements in the patent space. frankly i don't understand how the supreme court would make a distinction between the pharmaceutical space and say the technology space. why is it that google and everybody can settle their cases but we wouldn't be able to settle ours. >> reporter: however the supreme court rules, there's no denying that generic drug makers will continue to gain momentum as one way to trim the skyrocketing cost of health care. ruben ramirez, "n.b.r.," new york. >> susie: warren buffet was the hot topic of conversation here at the big board toda